Inhibitor Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQB
Inhibitor Therapeutics, Inc. has issued a proxy statement detailing its upcoming Annual Meeting of Stockholders on September 15, 2026, which includes proposals for director elections, auditor ratification, and the adoption of a new 2025 Share Incentive Plan.